Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
120.4 USD | +0.37% | -1.31% | -2.27% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.27% | 2.98B | B | ||
+13.43% | 64.66B | A- | ||
-3.80% | 46.08B | A- | ||
+13.26% | 39.72B | B+ | ||
+19.28% | 25.82B | A- | ||
+8.22% | 18.8B | C+ | ||
-0.60% | 17.14B | B+ | ||
-21.03% | 15.86B | A- | ||
+1.06% | 15.05B | B+ | ||
-17.64% | 14.14B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- IOSP Stock
- Ratings Innospec Inc.